Germany· DE-A57-489c17cbf8aabce0
Thioguanin Aspen
A tioguanine product containing tioguanine, registered in Germany by Aspen Pharma Trading Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Tioguanine is registered in 13 of 19 countries.
Countries holding a registration under ATC L01BB03 (tioguanine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Tioguanine · ATC L01BB03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Tioguanine
- Manufacturer
- Aspen Pharma Trading Limited
- Country
- Germany (DE)
- ATC code
- L01BB03
- ATC class
- Tioguanine
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for tioguanine.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tioguanine · interactions on record
434 records
- 33 severe
- 377 moderate
- 13 minor
- 11 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tioguanine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLanvis 40mg tabletsAspen Pharma Trading Ltd
- NetherlandsLanvis 40 mg tablettenAspen Pharma Trading Limited
- NorwayLanvisGlaxoSmithKline
- SpainLANVIS 40 MG COMPRIMIDOSAspen Pharma Trading Limited
- SwedenLanvis 40 mg TablettOrifarm AB
- IrelandLanvis 40mg TabletsAspen Pharma Trading Limited
- ItalyTIOGUANINA*25 cpr 40 mgASPEN PHARMA TRADING LIMITED
- PolandLanvisAspen Pharma Trading Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Thioguanin Aspen
- Belgium · Lanvis
- Czechia · Lanvis
- Estonia · Lanvis
- Spain · Lanvis
- France · Lanvis
- Ireland · Lanvis
- Italy · Tioguanina
- Lithuania · Lanvis
- Netherlands · Lanvis, Thiosix
- Poland · Lanvis
- Romania · Lanvis
- Sweden · Lanvis
- Slovakia · Lanvis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a409bcfb-529f-4494-b892-01c0aa4ed13d GET /v1/drugs/a409bcfb-529f-4494-b892-01c0aa4ed13d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Tioguanine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about tioguanine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.